Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role...
Saved in:
Published in | Cell death & disease Vol. 8; no. 10; p. e3071 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
05.10.2017
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of
β
-catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model
in vivo
showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment. |
---|---|
AbstractList | Abstract
MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of
β
-catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model
in vivo
showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment. MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β-catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment. MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer. However, the detail role of miR-451 has not been fully elucidated in breast cancer. In this study, we aimed to investigate the biological role and molecular mechanisms of miR-451 in drug resistance in breast cancer cell lines and in xenograft model. We show that miR-451 is decreased in human breast cancer specimens and in paclitaxel-resistant (PR) cells. Ectopic expression of miR-451 could inhibit the cell migration and invasion, promoted apoptosis, induced cell-cycle arrest Furthermore, tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein zeta (YWHAZ) was identified as a direct target of miR-451. Remarkably, the expression of YWHAZ is inversely correlated with the level of miR-451 in human breast cancer samples. Co-treatment with miR-451 mimics and YWHAZ-siRNA significantly enhanced YWHAZ knockdown in both SKBR3/PR and MCF-7/PR cells Moreover, miR-451 markedly inhibited expression of β -catenin via YWHAZ and subsequently inhibited downstream gene cyclin D1, c-Myc expression. The results of xenograft model in vivo showed that intratumor injection of miR-451 agomir induced a tumor-suppressive effect in SKBR3/PR drug-resistant xenograft model. Taken together, our findings suggested that miR-451 might be considered as important and potential target in paclitaxel-resistant breast cancer treatment. |
Author | Wang, Yangyang Li, Yu Duan, Kecai Zhang, Lingyu Chen, Sulian Ding, Yongxing Chen, Changjie Yang, Qingling Wang, Wenrui Chen, Tiantian Wang, Yueyue Wang, Haifeng |
Author_xml | – sequence: 1 givenname: Wenrui surname: Wang fullname: Wang, Wenrui organization: Department of Biotechnology, Bengbu Medical College – sequence: 2 givenname: Lingyu surname: Zhang fullname: Zhang, Lingyu organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College – sequence: 3 givenname: Yangyang surname: Wang fullname: Wang, Yangyang organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College, Clinical Laboratory, The First People’s Hospital of Changzhou – sequence: 4 givenname: Yongxing surname: Ding fullname: Ding, Yongxing organization: Department of Oncology, Bengbu Central Hospital – sequence: 5 givenname: Tiantian surname: Chen fullname: Chen, Tiantian organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College – sequence: 6 givenname: Yueyue surname: Wang fullname: Wang, Yueyue organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College – sequence: 7 givenname: Haifeng surname: Wang fullname: Wang, Haifeng organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College – sequence: 8 givenname: Yu surname: Li fullname: Li, Yu organization: Clinical Testing and Diagnose Experimental Center, Bengbu Medical College – sequence: 9 givenname: Kecai surname: Duan fullname: Duan, Kecai organization: Department of Oncology, Bengbu Central Hospital – sequence: 10 givenname: Sulian surname: Chen fullname: Chen, Sulian organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College – sequence: 11 givenname: Qingling surname: Yang fullname: Yang, Qingling email: yqlmimi@163.com organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College – sequence: 12 givenname: Changjie surname: Chen fullname: Chen, Changjie email: tochenchangjie@163.com organization: Department of Biochemistry and Molecular Biology, Bengbu Medical College |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28981108$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc9LHDEcxYNY_H31WAK9eJk1yWQymUtBxKogFEpF9BIymW_WyEyyJjOL_vfNula20lwSeJ_v--bx9tG2Dx4QOqZkRkkpT03XuTRjhNYzLsgW2mOE04JL2WxvvHfRUUpPJJ-yJKwSO2iXyUZSSuQeurv2y9AvYQA_4mDx4H4VvKLYeRwhuTRqbwCPAS-06d2oX6DH7WvW5lOvR-fn-P7u6uxhxbcRdBqxWU3EQ_TF6j7B0ft9gG5_XPw-vypufl5en5_dFKZifCxaZk1TGlkzK7quaw2xrBGVtbzW0gIpdSNAt0QYWoKuuaxtazSwUhChCe3KA_R97buY2gE6k2NE3atFdIOOrypop_5VvHtU87BUlZCkkiwbnLwbxPA8QRrV4JKBvtcewpQUbXgtGBGUZvTbJ_QpTNHneG8U4ZIzmanZmjIxpBTBfnyGErWqTb3Vpla1qVxbHvi6GeED_1tSBk7XQMqSn0Pc2Pt_yz8nK6Xt |
CitedBy_id | crossref_primary_10_1002_jbt_23613 crossref_primary_10_1016_j_talanta_2024_125777 crossref_primary_10_3390_ijms22116121 crossref_primary_10_1039_C7RA09042K crossref_primary_10_1016_j_prp_2023_154701 crossref_primary_10_3389_fmicb_2019_01659 crossref_primary_10_1007_s13258_020_01028_1 crossref_primary_10_1186_s12935_021_01885_0 crossref_primary_10_1016_j_prp_2021_153405 crossref_primary_10_1007_s11033_021_07010_8 crossref_primary_10_3389_fbioe_2021_762489 crossref_primary_10_3390_molecules23071578 crossref_primary_10_1245_s10434_024_15592_3 crossref_primary_10_1002_jcp_27445 crossref_primary_10_1038_s10038_018_0510_3 crossref_primary_10_3390_ncrna6030029 crossref_primary_10_3389_fonc_2022_848286 crossref_primary_10_1007_s12094_023_03189_3 crossref_primary_10_17650_1994_4098_2022_18_3_52_63 crossref_primary_10_21886_2308_6424_2022_10_4_98_108 crossref_primary_10_1080_15476286_2020_1851540 crossref_primary_10_1096_fj_202100294RR crossref_primary_10_1016_j_bcp_2021_114409 crossref_primary_10_1111_cpr_12648 crossref_primary_10_3390_ijms19041191 crossref_primary_10_1016_j_microc_2023_109260 crossref_primary_10_32604_oncologie_2022_022121 crossref_primary_10_1021_acs_jafc_0c07164 crossref_primary_10_1016_j_yexcr_2019_03_033 crossref_primary_10_1186_s40364_022_00361_9 crossref_primary_10_3390_ijms241612694 crossref_primary_10_1016_j_lfs_2020_117417 crossref_primary_10_19161_etd_1360783 crossref_primary_10_1016_j_ejphar_2020_173660 crossref_primary_10_2217_fon_2018_0741 crossref_primary_10_1007_s10911_021_09478_3 crossref_primary_10_1007_s11357_024_01260_7 crossref_primary_10_1002_jcp_29755 crossref_primary_10_1038_s41388_024_02959_9 crossref_primary_10_1038_s41419_018_0434_z crossref_primary_10_3390_cancers12092698 crossref_primary_10_1016_j_prp_2018_12_026 crossref_primary_10_1080_15384047_2018_1529091 crossref_primary_10_1177_1933719119862050 crossref_primary_10_3389_fonc_2021_634596 crossref_primary_10_2174_1389557520999201214234421 crossref_primary_10_1007_s12282_022_01359_9 crossref_primary_10_1016_j_omto_2021_08_001 crossref_primary_10_1111_1759_7714_14928 crossref_primary_10_1016_j_biopha_2020_111172 crossref_primary_10_1016_j_crphar_2022_100131 crossref_primary_10_3390_diagnostics11010107 crossref_primary_10_1002_jgm_3168 crossref_primary_10_1002_tox_22938 crossref_primary_10_1016_j_radmp_2024_02_005 crossref_primary_10_3390_ijms21175950 crossref_primary_10_1002_jcb_27915 crossref_primary_10_1186_s13148_018_0587_8 crossref_primary_10_1155_2020_9512793 crossref_primary_10_3390_ncrna5010025 crossref_primary_10_1002_jcp_30751 crossref_primary_10_1186_s12935_018_0709_6 crossref_primary_10_3389_fonc_2021_768949 crossref_primary_10_3389_fgene_2020_627459 crossref_primary_10_1016_j_gene_2019_02_066 crossref_primary_10_1186_s12885_021_09010_0 crossref_primary_10_20517_cdr_2023_19 crossref_primary_10_3390_ani10101891 crossref_primary_10_1016_j_yexcr_2021_112518 crossref_primary_10_1016_j_bcp_2019_07_014 crossref_primary_10_18632_aging_203315 crossref_primary_10_2147_CMAR_S253152 crossref_primary_10_1007_s10620_020_06705_5 crossref_primary_10_1002_jcp_28888 crossref_primary_10_1016_j_cancergen_2020_08_005 crossref_primary_10_1039_C8MD00187A crossref_primary_10_1089_dna_2020_6320 crossref_primary_10_1089_cbr_2020_3957 crossref_primary_10_2147_OTT_S282485 crossref_primary_10_3892_etm_2023_12173 |
Cites_doi | 10.1038/onc.2011.223 10.1002/stem.741 10.1002/wrna.1229 10.1158/0008-5472.CAN-07-6247 10.3727/096504016X14685034103798 10.1371/journal.pone.0073004 10.3892/or_00000963 10.3892/or.2014.3296 10.1016/j.addr.2015.05.001 10.1158/0008-5472.CAN-08-2765 10.1158/1535-7163.MCT-11-0548 10.1007/s13277-016-5219-3 10.1186/s12935-016-0290-9 10.1158/2159-8290.CD-13-0159 10.1038/nrg1379 10.1158/1541-7786.MCR-12-0189 10.18632/oncotarget.3065 10.1016/j.cellsig.2013.11.032 10.1016/j.brainres.2010.08.074 10.1158/1078-0432.CCR-08-1818 10.1186/s13058-015-0526-y 10.1038/cddis.2016.361 10.1158/1535-7163.MCT-08-0021 10.1038/srep37421 10.18632/oncotarget.5495 10.1038/bjc.2014.136 10.1038/cddis.2017.178 10.1074/jbc.M114.620252 10.1186/1756-9966-30-20 10.1590/1414-431X20133324 10.1038/srep17618 10.1016/j.canlet.2011.07.026 10.1016/j.biopha.2015.12.018 10.1186/s13058-014-0446-2 10.1038/cdd.2014.112 10.1158/0008-5472.CAN-05-1783 10.1111/j.1582-4934.2008.00510.x 10.33549/physiolres.932289 10.1083/jcb.200709091 10.7314/APJCP.2013.14.6.3631 10.1172/JCI86573 10.1016/j.humpath.2011.08.013 10.1158/2159-8290.CD-15-0893 |
ContentType | Journal Article |
Copyright | The Author(s) 2017 Copyright Nature Publishing Group Oct 2017 Copyright © 2017 The Author(s) 2017 The Author(s) |
Copyright_xml | – notice: The Author(s) 2017 – notice: Copyright Nature Publishing Group Oct 2017 – notice: Copyright © 2017 The Author(s) 2017 The Author(s) |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.1038/cddis.2017.460 |
DatabaseName | Springer Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Science Database Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Open Access url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Involvement of miR-451 in resistance to paclitaxel |
EISSN | 2041-4889 |
EndPage | e3071 |
ExternalDocumentID | 10_1038_cddis_2017_460 28981108 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABAWZ ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CAG CCPQU COF DIK DWQXO E3Z EBLON EBS EJD EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IPNFZ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RIG RNT RPM SNYQT TR2 UKHRP W2D CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c524t-b2fc93c872f6dddbc0f2965ff47a8fe03a96eab06c13ea7487fbcae23606a01d3 |
IEDL.DBID | RPM |
ISSN | 2041-4889 |
IngestDate | Tue Sep 17 21:13:34 EDT 2024 Fri Oct 25 21:48:45 EDT 2024 Thu Oct 10 17:11:27 EDT 2024 Fri Aug 23 01:18:58 EDT 2024 Wed Oct 16 00:59:50 EDT 2024 Fri Oct 11 20:48:54 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c524t-b2fc93c872f6dddbc0f2965ff47a8fe03a96eab06c13ea7487fbcae23606a01d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680582/ |
PMID | 28981108 |
PQID | 1947048428 |
PQPubID | 2041963 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5680582 proquest_miscellaneous_1947620611 proquest_journals_1947048428 crossref_primary_10_1038_cddis_2017_460 pubmed_primary_28981108 springer_journals_10_1038_cddis_2017_460 |
PublicationCentury | 2000 |
PublicationDate | 2017-10-05 |
PublicationDateYYYYMMDD | 2017-10-05 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2017 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Hammond (CR31) 2015; 87 Bergamaschi, Katzenellenbogen (CR34) 2012; 31 Singh, Gu, Agarwal (CR46) 2008; 68 Mao, Zhang, Deng, Mo, Yu, Lu (CR35) 2015; 5 Hong, Liang, Rehaman, Wang, Zhou, Zhou (CR8) 2016; 18 Sachdeva, Mito, Lee, Zhang, Li, Dodd (CR29) 2016; 126 Li, Mofunanya, Harris, Takemaru (CR32) 2008; 181 Schooneveld, Wildiers, Vergote, Vermeulen, Dirix, Van Laere (CR1) 2015; 17 Wilczynska, Bushell (CR30) 2015; 22 Fang, Feng, Wu, Srinivas, Yang, Fa (CR43) 2013; 8 Zhang, Geng, Talmon, Wang (CR12) 2015; 290 Zhu, Zou, Nie, Kou, Wu, Wang (CR15) 2016; 7 Bian, Pan, Yang, Wang, De (CR28) 2011; 30 Nishimura, Jung, Shah, Lu, Spizzo, Shimizu (CR38) 2013; 3 Guo, Xiao, Sun, Liu (CR42) 2012; 61 Kovalchuk, Filkowski, Meservy, Ilnytskyy, Tryndyak, Chekhun (CR27) 2008; 7 Zhang, Liu, Feng, Mao, Zhang, Lu (CR10) 2016; 77 Li, Zhang, Cai, Bian (CR23) 2013; 29 Bitarte, Bandres, Boni, Zarate, Rodriguez, Gonzalez-Huarriz (CR18) 2011; 29 Rizvi, Truong, Truong (CR2) 2017; 9 Xu, Hu, Shen, Shen (CR5) 2016; 16 Wang, Tian, Jiang, Wang, Li, She (CR17) 2011; 311 Shah, Calin (CR37) 2014; 5 Zhang, Gill, Issacs, Atmore, Johns, Delbridge (CR41) 2012; 43 Neal, Yao, Yang, Zhou, Nguyen, Lu (CR33) 2009; 69 De Mattos-Arruda, Bottai, Nuciforo, Di Tommaso, Giovannetti, Peg (CR14) 2015; 6 Wang, Zhan, Xu, Chen, Long, Shi (CR13) 2017; 8 Wang, Chen, Meng, Jing, Lu, Yang (CR44) 2015; 5 Rupaimoole, Calin, Lopez-Berestein, Sood (CR22) 2016; 6 He, Hannon (CR6) 2004; 5 Iorio, Ferracin, Liu, Veronese, Spizzo, Sabbioni (CR7) 2005; 65 Fang, Shen, Cao, Li, Qin, Chen (CR36) 2014; 47 Bandres, Bitarte, Arias, Agorreta, Fortes, Agirre (CR26) 2009; 15 Krausova, Korinek (CR40) 2014; 26 Chen, Chuang, Yang, Liao, Yu, Chen (CR21) 2012; 10 Howell, Anderson, Clarke, Duffy, Evans, Closas (CR3) 2014; 16 Zhang, Kim, Jin, Pfent, Cao, Amendt (CR11) 2012; 11 Lv, Hu, Tie, Du, Fu, Gao (CR25) 2014; 32 Guo, Nan, Zhen, Zhang, Guo, Kai (CR19) 2016; 37 Wang, Song, Shen, Sun, Qu, Shang (CR20) 2017; 25 Wang, Lee (CR9) 2009; 13 Su, Zhang, Shi, Ma, Pu, Wang (CR39) 2012; 40 Yang, Wang, Lu, Zhao, Zhu, Chen (CR16) 2015; 6 Hassan, Ansari, Spooner, Hussain (CR4) 2010; 24 Yang, Huang, Wu, Cai, Zhu, Lu (CR45) 2014; 110 Nan, Han, Zhang, Wang, Jia, Yang (CR24) 2010; 1359 24642627 - Br J Cancer. 2014 Apr 15;110(8):1958-67 22034498 - Mol Cancer Ther. 2012 Jan;11(1):108-18 24308963 - Cell Signal. 2014 Mar;26(3):570-9 23886157 - Asian Pac J Cancer Prev. 2013;14(6):3631-4 20878101 - Oncol Rep. 2010 Nov;24(5):1121-31 22211245 - Int J Oncol. 2012 Apr;40(4):1162-70 18645025 - Mol Cancer Ther. 2008 Jul;7(7):2152-9 19318487 - Clin Cancer Res. 2009 Apr 1;15(7):2281-90 22670697 - Physiol Res. 2012;61(4):337-46 21329503 - J Exp Clin Cancer Res. 2011 Feb 17;30:20 20816946 - Brain Res. 2010 Nov 4;1359:14-21 16103053 - Cancer Res. 2005 Aug 15;65(16):7065-70 15211354 - Nat Rev Genet. 2004 Jul;5(7):522-31 26620926 - Sci Rep. 2015 Dec 01;5:17618 25616665 - J Biol Chem. 2015 Mar 6;290(10):6215-25 25849621 - Breast Cancer Res. 2015 Feb 18;17:21 27476171 - Tumour Biol. 2016 Oct;37(10 ):13751-13761 26865249 - Cancer Discov. 2016 Mar;6(3):235-46 26796277 - Biomed Pharmacother. 2016 Feb;77:135-41 27857177 - Sci Rep. 2016 Nov 18;6:37421 22204713 - Hum Pathol. 2012 Jul;43(7):1044-50 27035817 - J Clin Invest. 2016 Apr 1;126(4):1606 24968707 - Oncol Rep. 2014 Sep;32(3):1021-8 18573912 - J Cell Biol. 2008 Jun 30;181(7):1141-54 21875770 - Cancer Lett. 2011 Dec 8;311(2):203-9 27809310 - Cell Death Dis. 2016 Nov 3;7(11):e2454 25979468 - Adv Drug Deliv Rev. 2015 Jun 29;87:3-14 26900348 - Cancer Cell Int. 2016 Feb 20;16:13 24687772 - Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):537-48 25605244 - Oncotarget. 2015 Feb 20;6(5):3268-79 21666713 - Oncogene. 2012 Jan 5;31(1):39-47 24002999 - Cancer Discov. 2013 Nov;3(11):1302-15 22912335 - Mol Cancer Res. 2012 Oct;10(10):1319-31 26452030 - Oncotarget. 2015 Nov 10;6(35):37269-80 28081727 - Oncol Res. 2017 Jan 2;25(1):1-10 19318578 - Cancer Res. 2009 Apr 15;69(8):3425-32 28492560 - Cell Death Dis. 2017 May 11;8(5):e2770 18339887 - Cancer Res. 2008 Mar 15;68(6):2043-50 25190144 - Cell Death Differ. 2015 Jan;22(1):22-33 19175697 - J Cell Mol Med. 2009 Jan;13(1):12-23 26269755 - Am J Cancer Res. 2015 May 15;5(6):1939-53 25467785 - Breast Cancer Res. 2014 Sep 28;16(5):446 28706762 - Cureus. 2017 Jun 11;9(6):e1337 21948564 - Stem Cells. 2011 Nov;29(11):1661-71 24519092 - Braz J Med Biol Res. 2014 Jan;47(1):60-9 24015284 - PLoS One. 2013 Aug 27;8(8):e73004 QL Yang (BFcddis2017460_CR16) 2015; 6 MY Shah (BFcddis2017460_CR37) 2014; 5 FQ Li (BFcddis2017460_CR32) 2008; 181 CL Neal (BFcddis2017460_CR33) 2009; 69 S Zhang (BFcddis2017460_CR11) 2012; 11 XY Wang (BFcddis2017460_CR44) 2015; 5 MS Hassan (BFcddis2017460_CR4) 2010; 24 HB Guo (BFcddis2017460_CR19) 2016; 37 Y Guo (BFcddis2017460_CR42) 2012; 61 Y Wang (BFcddis2017460_CR9) 2009; 13 O Kovalchuk (BFcddis2017460_CR27) 2008; 7 HB Bian (BFcddis2017460_CR28) 2011; 30 A Howell (BFcddis2017460_CR3) 2014; 16 H Wang (BFcddis2017460_CR13) 2017; 8 R Rupaimoole (BFcddis2017460_CR22) 2016; 6 HY Li (BFcddis2017460_CR23) 2013; 29 G Lv (BFcddis2017460_CR25) 2014; 32 J Zhang (BFcddis2017460_CR41) 2012; 43 Y Fang (BFcddis2017460_CR43) 2013; 8 J Su (BFcddis2017460_CR39) 2012; 40 A Bergamaschi (BFcddis2017460_CR34) 2012; 31 Y Fang (BFcddis2017460_CR36) 2014; 47 L De Mattos-Arruda (BFcddis2017460_CR14) 2015; 6 M Sachdeva (BFcddis2017460_CR29) 2016; 126 JH Xu (BFcddis2017460_CR5) 2016; 16 Y Zhang (BFcddis2017460_CR12) 2015; 290 YT Hong (BFcddis2017460_CR8) 2016; 18 J Zhang (BFcddis2017460_CR10) 2016; 77 EV Schooneveld (BFcddis2017460_CR1) 2015; 17 Y Nan (BFcddis2017460_CR24) 2010; 1359 QL Yang (BFcddis2017460_CR45) 2014; 110 E Bandres (BFcddis2017460_CR26) 2009; 15 MV Iorio (BFcddis2017460_CR7) 2005; 65 M Nishimura (BFcddis2017460_CR38) 2013; 3 XC Wang (BFcddis2017460_CR17) 2011; 311 N Bitarte (BFcddis2017460_CR18) 2011; 29 CH Chen (BFcddis2017460_CR21) 2012; 10 J Wang (BFcddis2017460_CR20) 2017; 25 SM Hammond (BFcddis2017460_CR31) 2015; 87 A Wilczynska (BFcddis2017460_CR30) 2015; 22 M Krausova (BFcddis2017460_CR40) 2014; 26 LY Mao (BFcddis2017460_CR35) 2015; 5 RP Singh (BFcddis2017460_CR46) 2008; 68 W Rizvi (BFcddis2017460_CR2) 2017; 9 J Zhu (BFcddis2017460_CR15) 2016; 7 L He (BFcddis2017460_CR6) 2004; 5 |
References_xml | – volume: 32 start-page: 1021 year: 2014 end-page: 1028 ident: CR25 article-title: MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration publication-title: Oncol Rep contributor: fullname: Gao – volume: 9 start-page: e1337 year: 2017 ident: CR2 article-title: Metastatic breast cancer with BRCA mutation discovered by next-generation sequencing responding to olaparib publication-title: Cureus contributor: fullname: Truong – volume: 290 start-page: 6215 year: 2015 end-page: 6225 ident: CR12 article-title: MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer publication-title: J Biol Chem contributor: fullname: Wang – volume: 311 start-page: 203 year: 2011 end-page: 220 ident: CR17 article-title: The expression and function of miRNA-451 in non-small cell lung cancer publication-title: Cancer Lett contributor: fullname: She – volume: 31 start-page: 39 year: 2012 end-page: 47 ident: CR34 article-title: Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance publication-title: Oncogene contributor: fullname: Katzenellenbogen – volume: 6 start-page: 37269 year: 2015 end-page: 37280 ident: CR14 article-title: MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients publication-title: Oncotarget contributor: fullname: Peg – volume: 29 start-page: 1661 year: 2011 end-page: 1671 ident: CR18 article-title: MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells publication-title: Stem Cells contributor: fullname: Gonzalez-Huarriz – volume: 26 start-page: 570 year: 2014 end-page: 579 ident: CR40 article-title: Wnt signaling in adult intestinal stem cells and cancer publication-title: Cell Signal contributor: fullname: Korinek – volume: 16 start-page: 13 year: 2016 ident: CR5 article-title: Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy publication-title: Cancer Cell Int contributor: fullname: Shen – volume: 15 start-page: 2281 year: 2009 end-page: 2290 ident: CR26 article-title: MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells publication-title: Clin Cancer Res contributor: fullname: Agirre – volume: 65 start-page: 7065 year: 2005 end-page: 7070 ident: CR7 article-title: MicroRNA gene expression deregulation in human breast cancer publication-title: Cancer Res contributor: fullname: Sabbioni – volume: 87 start-page: 3 year: 2015 end-page: 14 ident: CR31 article-title: An overview of microRNAs publication-title: Adv Drug Deliv Rev. contributor: fullname: Hammond – volume: 181 start-page: 1141 year: 2008 end-page: 1154 ident: CR32 article-title: Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity publication-title: J Cell Biol contributor: fullname: Takemaru – volume: 13 start-page: 12 year: 2009 end-page: 23 ident: CR9 article-title: MicroRNA and cancer–focus on apoptosis publication-title: J Cell Mol Med contributor: fullname: Lee – volume: 22 start-page: 22 year: 2015 end-page: 33 ident: CR30 article-title: The complexity of miRNA-mediated repression publication-title: Cell Death Differ contributor: fullname: Bushell – volume: 25 start-page: 1 year: 2017 end-page: 10 ident: CR20 article-title: MicroRNA-200a suppresses cell invasion and migration by directly targeting GAB1 in hepatocellular carcinoma publication-title: Oncol Res contributor: fullname: Shang – volume: 8 start-page: e2770 year: 2017 ident: CR13 article-title: miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer publication-title: Cell Death Dis contributor: fullname: Shi – volume: 17 start-page: 21 year: 2015 ident: CR1 article-title: Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management publication-title: Breast Cancer Res contributor: fullname: Van Laere – volume: 47 start-page: 60 year: 2014 end-page: 69 ident: CR36 article-title: Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells publication-title: Braz J Med Biol Res contributor: fullname: Chen – volume: 5 start-page: 17618 year: 2015 ident: CR44 article-title: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC publication-title: Sci Rep contributor: fullname: Yang – volume: 11 start-page: 108 year: 2012 end-page: 118 ident: CR11 article-title: Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells publication-title: Mol Cancer Ther contributor: fullname: Amendt – volume: 40 start-page: 1162 year: 2012 end-page: 1170 ident: CR39 article-title: MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin publication-title: Int J Oncol contributor: fullname: Wang – volume: 6 start-page: 3268 year: 2015 end-page: 3279 ident: CR16 article-title: MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells publication-title: Oncotarget contributor: fullname: Chen – volume: 5 start-page: 537 year: 2014 end-page: 548 ident: CR37 article-title: MicroRNAs as therapeutic targets in human cancers publication-title: Wiley Interdiscip Rev RNA contributor: fullname: Calin – volume: 69 start-page: 3425 year: 2009 end-page: 3432 ident: CR33 article-title: 14-3-3ζ overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival publication-title: Cancer Res contributor: fullname: Lu – volume: 24 start-page: 1121 year: 2010 end-page: 1131 ident: CR4 article-title: Chemotherapy for breast cancer (review) publication-title: Oncol Rep contributor: fullname: Hussain – volume: 37 start-page: 13751 year: 2016 end-page: 13761 ident: CR19 article-title: MiRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1 publication-title: Tumour Biol contributor: fullname: Kai – volume: 68 start-page: 2043 year: 2008 end-page: 2050 ident: CR46 article-title: Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis publication-title: Cancer Res contributor: fullname: Agarwal – volume: 6 start-page: 235 year: 2016 end-page: 246 ident: CR22 article-title: MicroRNA deregulation in cancer cells and the tumor microenvironment publication-title: Cancer Discov contributor: fullname: Sood – volume: 43 start-page: 1044 year: 2012 end-page: 1050 ident: CR41 article-title: The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer publication-title: Hum Pathol contributor: fullname: Delbridge – volume: 29 start-page: 3631 year: 2013 end-page: 3634 ident: CR23 article-title: MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway publication-title: Asian Pac J Cancer Prev contributor: fullname: Bian – volume: 126 start-page: 1606 year: 2016 ident: CR29 article-title: MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes publication-title: J Clin Invest contributor: fullname: Dodd – volume: 16 start-page: 446 year: 2014 ident: CR3 article-title: Risk determination and prevention of breast cancer publication-title: Breast Cancer Res. contributor: fullname: Closas – volume: 77 start-page: 135 year: 2016 end-page: 141 ident: CR10 article-title: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin publication-title: Biomed Pharmacother contributor: fullname: Lu – volume: 5 start-page: 522 year: 2004 end-page: 531 ident: CR6 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat Rev Genet contributor: fullname: Hannon – volume: 5 start-page: 1939 year: 2015 end-page: 1953 ident: CR35 article-title: Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer publication-title: Am J Cancer Res contributor: fullname: Lu – volume: 7 start-page: e2454 year: 2016 ident: CR15 article-title: Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression publication-title: Cell Death Dis contributor: fullname: Wang – volume: 10 start-page: 1319 year: 2012 end-page: 1331 ident: CR21 article-title: A novel function of YWHAZ/β-catenin axis in promoting epithelial–mesenchymal transition and lung cancer metastasis publication-title: Mol Cancer Res contributor: fullname: Chen – volume: 30 start-page: 20 year: 2011 ident: CR28 article-title: Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549) publication-title: J Exp Clin Cancer Res contributor: fullname: De – volume: 7 start-page: 2152 year: 2008 end-page: 2159 ident: CR27 article-title: Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin publication-title: Mol Cancer Ther contributor: fullname: Chekhun – volume: 8 start-page: e73004 year: 2013 ident: CR43 article-title: Aflatoxin B1 negatively regulates Wnt/β-catenin signaling pathway through activating miR-33a publication-title: PLoS ONE contributor: fullname: Fa – volume: 61 start-page: 337 year: 2012 end-page: 346 ident: CR42 article-title: Wnt/β-catenin signaling: a promising new target for fibrosis diseases publication-title: Physiol Res contributor: fullname: Liu – volume: 1359 start-page: 14 year: 2010 end-page: 21 ident: CR24 article-title: MiRNA-451 plays a role as tumor suppressor in human glioma cells publication-title: Brain Res contributor: fullname: Yang – volume: 110 start-page: 1958 year: 2014 end-page: 1967 ident: CR45 article-title: Acquisition of epithelial mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells publication-title: Br J Cancer contributor: fullname: Lu – volume: 3 start-page: 1302 year: 2013 end-page: 1315 ident: CR38 article-title: Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment publication-title: Cancer Discov contributor: fullname: Shimizu – volume: 18 start-page: 37421 year: 2016 ident: CR8 article-title: MiR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer publication-title: Sci Rep contributor: fullname: Zhou – volume: 31 start-page: 39 year: 2012 ident: BFcddis2017460_CR34 publication-title: Oncogene doi: 10.1038/onc.2011.223 contributor: fullname: A Bergamaschi – volume: 29 start-page: 1661 year: 2011 ident: BFcddis2017460_CR18 publication-title: Stem Cells doi: 10.1002/stem.741 contributor: fullname: N Bitarte – volume: 5 start-page: 537 year: 2014 ident: BFcddis2017460_CR37 publication-title: Wiley Interdiscip Rev RNA doi: 10.1002/wrna.1229 contributor: fullname: MY Shah – volume: 68 start-page: 2043 year: 2008 ident: BFcddis2017460_CR46 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6247 contributor: fullname: RP Singh – volume: 25 start-page: 1 year: 2017 ident: BFcddis2017460_CR20 publication-title: Oncol Res doi: 10.3727/096504016X14685034103798 contributor: fullname: J Wang – volume: 8 start-page: e73004 year: 2013 ident: BFcddis2017460_CR43 publication-title: PLoS ONE doi: 10.1371/journal.pone.0073004 contributor: fullname: Y Fang – volume: 5 start-page: 1939 year: 2015 ident: BFcddis2017460_CR35 publication-title: Am J Cancer Res contributor: fullname: LY Mao – volume: 40 start-page: 1162 year: 2012 ident: BFcddis2017460_CR39 publication-title: Int J Oncol contributor: fullname: J Su – volume: 24 start-page: 1121 year: 2010 ident: BFcddis2017460_CR4 publication-title: Oncol Rep doi: 10.3892/or_00000963 contributor: fullname: MS Hassan – volume: 32 start-page: 1021 year: 2014 ident: BFcddis2017460_CR25 publication-title: Oncol Rep doi: 10.3892/or.2014.3296 contributor: fullname: G Lv – volume: 9 start-page: e1337 year: 2017 ident: BFcddis2017460_CR2 publication-title: Cureus contributor: fullname: W Rizvi – volume: 87 start-page: 3 year: 2015 ident: BFcddis2017460_CR31 publication-title: Adv Drug Deliv Rev. doi: 10.1016/j.addr.2015.05.001 contributor: fullname: SM Hammond – volume: 69 start-page: 3425 year: 2009 ident: BFcddis2017460_CR33 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2765 contributor: fullname: CL Neal – volume: 11 start-page: 108 year: 2012 ident: BFcddis2017460_CR11 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-11-0548 contributor: fullname: S Zhang – volume: 37 start-page: 13751 year: 2016 ident: BFcddis2017460_CR19 publication-title: Tumour Biol doi: 10.1007/s13277-016-5219-3 contributor: fullname: HB Guo – volume: 16 start-page: 13 year: 2016 ident: BFcddis2017460_CR5 publication-title: Cancer Cell Int doi: 10.1186/s12935-016-0290-9 contributor: fullname: JH Xu – volume: 3 start-page: 1302 year: 2013 ident: BFcddis2017460_CR38 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-13-0159 contributor: fullname: M Nishimura – volume: 5 start-page: 522 year: 2004 ident: BFcddis2017460_CR6 publication-title: Nat Rev Genet doi: 10.1038/nrg1379 contributor: fullname: L He – volume: 10 start-page: 1319 year: 2012 ident: BFcddis2017460_CR21 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-12-0189 contributor: fullname: CH Chen – volume: 6 start-page: 3268 year: 2015 ident: BFcddis2017460_CR16 publication-title: Oncotarget doi: 10.18632/oncotarget.3065 contributor: fullname: QL Yang – volume: 26 start-page: 570 year: 2014 ident: BFcddis2017460_CR40 publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.11.032 contributor: fullname: M Krausova – volume: 1359 start-page: 14 year: 2010 ident: BFcddis2017460_CR24 publication-title: Brain Res doi: 10.1016/j.brainres.2010.08.074 contributor: fullname: Y Nan – volume: 15 start-page: 2281 year: 2009 ident: BFcddis2017460_CR26 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-1818 contributor: fullname: E Bandres – volume: 17 start-page: 21 year: 2015 ident: BFcddis2017460_CR1 publication-title: Breast Cancer Res doi: 10.1186/s13058-015-0526-y contributor: fullname: EV Schooneveld – volume: 7 start-page: e2454 year: 2016 ident: BFcddis2017460_CR15 publication-title: Cell Death Dis doi: 10.1038/cddis.2016.361 contributor: fullname: J Zhu – volume: 7 start-page: 2152 year: 2008 ident: BFcddis2017460_CR27 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-08-0021 contributor: fullname: O Kovalchuk – volume: 18 start-page: 37421 year: 2016 ident: BFcddis2017460_CR8 publication-title: Sci Rep doi: 10.1038/srep37421 contributor: fullname: YT Hong – volume: 6 start-page: 37269 year: 2015 ident: BFcddis2017460_CR14 publication-title: Oncotarget doi: 10.18632/oncotarget.5495 contributor: fullname: L De Mattos-Arruda – volume: 110 start-page: 1958 year: 2014 ident: BFcddis2017460_CR45 publication-title: Br J Cancer doi: 10.1038/bjc.2014.136 contributor: fullname: QL Yang – volume: 8 start-page: e2770 year: 2017 ident: BFcddis2017460_CR13 publication-title: Cell Death Dis doi: 10.1038/cddis.2017.178 contributor: fullname: H Wang – volume: 290 start-page: 6215 year: 2015 ident: BFcddis2017460_CR12 publication-title: J Biol Chem doi: 10.1074/jbc.M114.620252 contributor: fullname: Y Zhang – volume: 30 start-page: 20 year: 2011 ident: BFcddis2017460_CR28 publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-30-20 contributor: fullname: HB Bian – volume: 47 start-page: 60 year: 2014 ident: BFcddis2017460_CR36 publication-title: Braz J Med Biol Res doi: 10.1590/1414-431X20133324 contributor: fullname: Y Fang – volume: 5 start-page: 17618 year: 2015 ident: BFcddis2017460_CR44 publication-title: Sci Rep doi: 10.1038/srep17618 contributor: fullname: XY Wang – volume: 311 start-page: 203 year: 2011 ident: BFcddis2017460_CR17 publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.07.026 contributor: fullname: XC Wang – volume: 77 start-page: 135 year: 2016 ident: BFcddis2017460_CR10 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2015.12.018 contributor: fullname: J Zhang – volume: 16 start-page: 446 year: 2014 ident: BFcddis2017460_CR3 publication-title: Breast Cancer Res. doi: 10.1186/s13058-014-0446-2 contributor: fullname: A Howell – volume: 22 start-page: 22 year: 2015 ident: BFcddis2017460_CR30 publication-title: Cell Death Differ doi: 10.1038/cdd.2014.112 contributor: fullname: A Wilczynska – volume: 65 start-page: 7065 year: 2005 ident: BFcddis2017460_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1783 contributor: fullname: MV Iorio – volume: 13 start-page: 12 year: 2009 ident: BFcddis2017460_CR9 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2008.00510.x contributor: fullname: Y Wang – volume: 61 start-page: 337 year: 2012 ident: BFcddis2017460_CR42 publication-title: Physiol Res doi: 10.33549/physiolres.932289 contributor: fullname: Y Guo – volume: 181 start-page: 1141 year: 2008 ident: BFcddis2017460_CR32 publication-title: J Cell Biol doi: 10.1083/jcb.200709091 contributor: fullname: FQ Li – volume: 29 start-page: 3631 year: 2013 ident: BFcddis2017460_CR23 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2013.14.6.3631 contributor: fullname: HY Li – volume: 126 start-page: 1606 year: 2016 ident: BFcddis2017460_CR29 publication-title: J Clin Invest doi: 10.1172/JCI86573 contributor: fullname: M Sachdeva – volume: 43 start-page: 1044 year: 2012 ident: BFcddis2017460_CR41 publication-title: Hum Pathol doi: 10.1016/j.humpath.2011.08.013 contributor: fullname: J Zhang – volume: 6 start-page: 235 year: 2016 ident: BFcddis2017460_CR22 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-15-0893 contributor: fullname: R Rupaimoole |
SSID | ssj0000330256 |
Score | 2.5095868 |
Snippet | MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast cancer.... Abstract MicroRNAs (miRNAs) have been identified as major post-transcriptional regulators of the initiation and progression of human cancers, including breast... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e3071 |
SubjectTerms | 14-3-3 Proteins - genetics 631/337/384/331 631/67/1059/2326 631/67/1059/602 692/699/67/1347 Animals Antibodies Apoptosis Apoptosis - genetics Biochemistry Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - genetics Breast Neoplasms - pathology c-Myc protein Cell adhesion & migration Cell Biology Cell Culture Cell migration Cell Movement - genetics Cell Proliferation - genetics Cyclin D1 Drug resistance Drug Resistance, Neoplasm - genetics Ectopic expression Female Gene expression Gene Expression Regulation, Neoplastic Humans Immunology Life Sciences MCF-7 Cells Mice MicroRNAs - genetics miRNA Molecular modelling Monooxygenase Myc protein Original original-article Paclitaxel Paclitaxel - administration & dosage Paclitaxel - adverse effects Post-transcription siRNA Transcription Tumor cell lines Xenograft Model Antitumor Assays Xenografts β-Catenin |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS98wED_cVwZ7GdO5rZuTCIP50tkmbdI-DSfKdwNFZKLbS0nShH1BW6cV5n-_u7T9-hNf-pIrae6uyX3uLncAn4zNJE98GZecXDcizWKTCnxwhweGUlqVdMF5b19Oj7IfJ_nJ4HC7HNIqxz0xbNR1a8lHvolgW6G2obX89fxvTF2jKLo6tNB4BosckUIygcVvO_sHh3MvS4JwHQ_1sVqjKDYtpelQSpf6koW6lLdOowcm5sNMyXvh0nAK7b6Cl4P5yLZ6eS_BgmuW4XnfUPL6NRx_b3C7CSXAO9Z6djY7jLM8ZbOGIawmUxFlzLqWIVKm6tz_3Ckz1zgWGtLjjOzX8XTrN9EbylbvmKU3LlbgaHfn5_Y0HlonxDbnWYes9rYUtlDcy7qujU08L2XufaZ04V0idCmdNom0qXBaIWrxxmrHBeIZnaS1eAOTpm3cO2AaLazaOI2mgc5ErQpqQWVdjVjIo3koI_g8srA67ytkVCGyLYoqMLsiZlfI7AhWRw5Xw59yWd3INYL1-TDqOAUudOPaq54GNUqmaQRve4HMp0LAWNBVhgjUHVHNCah-9t2RZvYn1NHOZZHkBY9gYxTqrc96dAXvn17BB3hBlCHXL1-FSXdx5T6izdKZtUEx_wO0z-3n priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwEB2hIiQuqOUz0CIjIcElJbEd2zmgqkJUCxIcEKsWLpHt2GKlkqVLKnX_fWeczcKy5ZJDPJaTmYk9L36eAXjpvFS8iHVec_p1I0qZu1LghQdcMLS2uqYDzp8-q8lUfjyrzv7wn1YK_H0jtKN6UtPF-eHVxfIIP_i3w5Fx88YT84ZYWvpQKoTvt7lElE40vlWon2ZlvIXL-5i3casbZQU2tSFW_OYStRV3btMn_9lDTUvTyS7cW8WU7Hhwgj24Fbr7cGeoMrl8AKcfOpyDUl7wns0j-zn7ksuqZLOOIdam-BENz_o5Q_hMKbuvwjlzS2xLVepxRPbtdHL8neQdUdh75qnH4iFMT95_fTfJV_UUcl9x2aP-o6-FN5pH1bat80XktapilNqaGAphaxWsK5QvRbAaoUx03gYuEOTYomzFI9jp5l14Asxi2NW6YDFesFK02lBdKh9aBEgRY0aVwatRhc2vIW1Gk7a7hWmS3hvSe4N6z2B_1HAzWr8pa6lxakFolMGLdTM6Pu1m2C7MLwcZdDNVlhk8HgyyHmq0ZAZ6w1RrAUqqvdnSzX6k5NqVMkVleAavR6P-9Vg3vsHT_w7_DO6SUOL-Vfuw0y8uwwHGML17npzzGoVA74E priority: 102 providerName: Scholars Portal – databaseName: Springer Open Access dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEB8O5eBeRL0P6xc5ELyX3rVNmqSPsriswt2DuOx6LyVJE1zwusdaQf97Z9rdxXV98KUUMiHNTJqZX2YyA3BinZBZEoq4yOjohqcitinHR-ZRYShlVEEXnH__kYOhuBzn43mALN2FWfHfc_3LUVQNRWCpn0IiNN9E_aspdKsne8uzlARBOaruRU7GtW6rOmfNkFyPh3zlFG11TX8btuZGIjvrpLoDH3y9Cx-7spFPn2F0UeOm0ib6btg0sH-Tq1jkKZvUDMEzGYQoSdZMGeJhysH96O-YfcK2tuw8jshuRoOzv0RvKSa9YY56zL7AsH9-3RvE8wIJscsz0SBDgyu40yoLsqoq65KQFTIPQSijg0-4KaQ3NpEu5d4oxCbBOuMzjqjFJGnFv8JGPa39HjCDdlRlvUEDwAheKU2FppyvEPEENAJlBKcLFpb_uzwYZeu_5rpsmV0Ss0tkdgSHCw6X8__hvkwLoXCvQKwTwfdlM65kck-Y2k8fOhpcNzJNI_jWCWQ5FMJCTRcWIlAroloSUJbs1ZZ6cttmy86lTnKdRfBjIdQXn_XmDPbfT3oAn-i1je7LD2GjmT34I7RSGnvcLtFny0TlIw priority: 102 providerName: Springer Nature |
Title | Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer |
URI | https://link.springer.com/article/10.1038/cddis.2017.460 https://www.ncbi.nlm.nih.gov/pubmed/28981108 https://www.proquest.com/docview/1947048428 https://search.proquest.com/docview/1947620611 https://pubmed.ncbi.nlm.nih.gov/PMC5680582 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_6wWAvZes-6q0zGgy6Fye2JUvyYxda0kK6Ulqa7cVIskQDjVM6F9b_fic5Ds26p70YjGRLvjtL95N-ugP4og3jeerKpMz90g3NWKIzipfc4oQhhBKlP-A8OePjK3Y6LaYbUPRnYQJp3-jZoLmdD5rZTeBW3s3NsOeJDc8no4LLtJD5cBM20UCfQPQw_CJCx3m8D9BI5dB4Zo5ncYkB4z71G4IM6env63PRMwfzOU_yr83SMAcdv4KdpfNIDrtOvoYN2-zCiy6d5OMbuD5pcLAJAcBbsnBkPrtIWJGRWUMQVHtHETVM2gVBnOxjc_-2t0Q_YllIR48tkh_X48Ofvr72XPWWGP_E_Vu4Oj66HI2TZeKExBQ5a1HQzpTUSJE7Xte1NqnLS144x4SSzqZUldwqnXKTUasEYhanjbI5RTSj0qym72CrWTR2D4hC_6rWVqFjoBithfQJqIytEQk5dA55BAe9CKu7Lj5GFfa1qayC3Csv9wrlHsF-L-Fq-Z_8qrKSCRxDEANF8HlVjBbuty1UYxcPXR20J55lEbzvFLJqqtdkBGJNVasKPnr2egkaVYiivTSiCL72Sn3SrX9-wYf_buQjvPQvCSTAYh-22vsH-wmdmVbHaMJTEcP2t6Oz8wu8G_FRHBYG8DphMvarht_jYOJ_AJHh-6s |
link.rule.ids | 230,315,730,783,787,867,888,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,41132,42201,43322,43817,51588,53804,53806,74079,74636 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT90wDLc2pmlcEGMMCmwLEtJ2KbRNm7QnhNDQY3wcEIgHlypJE_Ek1jIo0vjvZ6ftA8a0Sy9JlNZ2Y_9sxwbY0CYVSeSKsEjIdcPjNNQxx0diUWFIqWRBF5yPjsXoLP0xzsa9w-2uT6sczkR_UFeNIR_5FoJtidKG1vL2za-QukZRdLVvofEa3lAdLupgIMdy6mOJEKyjSh9qNfJ8y1CSDiV0yc3UV6V8ooteGJgv8yT_CpZ6HbQ3D3O98ch2Om6_h1e2XoC3XTvJhw9wvl_jYeMLgLescezn5CRMs5hNaoagmgxF5DBrG4Y4mWpz_7bXTD_gmG9Hjzuyi_PRziXN15Sr3jJDK24X4Wzv--nuKOwbJ4QmS9IWCe1MwU0uEyeqqtImckkhMudSqXJnI64KYZWOhIm5VRIxi9NG2YQjmlFRXPGPMFM3tV0GptC-qrRVaBiolFcypwZUxlaIhBwahyKArwMJy5uuPkbp49o8Lz2xSyJ2icQOYG2gcNn_J3flI1cDWJ8Oo4RT2ELVtrnv5qA8iTgOYKljyHQrhIs5XWQIQD5j1XQCVc9-PlJPrnwV7UzkUZYnAXwbmPrktf75BSv__4Iv8G50enRYHu4fH6zCLK3yWX_ZGsy0t_f2E1ovrf7sRfQPC47vcg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9UwFD5RDMYXoyA4RS0JCb7Mu61buz0Zot5c5EcIkXD1ZWm7NtwENoSRyH_vOd12ASG-7KVtup1z1p6v5-s5ABvapCKJXBEWCR3d8DgNdczxkVjcMKRUsqALznv7YnKUfp9m057_dNnTKoc10S_UVWPojHyEYFuitaG3PHI9LeLg6_jz-e-QKkhRpLUvp_EYnkhEKWThcirn5y0RAnfc3oe8jTwfGSLsELlLfkp9hspb-9I9Z_M-Z_KfwKnfj8Yv4HnvSLKtTvMv4ZGtl2CxKy15vQzH2zUuPD4ZeMsax85mh2GaxWxWMwTY5DSitlnbMMTMlKf7jz1l-hrbfGl6nJH9PJ5s_aL-mnjrLTM04uIVHI2__fgyCfsiCqHJkrRFoTtTcJPLxImqqrSJXFKIzLlUqtzZiKtCWKUjYWJulUT84rRRNuGIbFQUV3wFFuqmtq-BKfS1Km0VOgkq5ZXMqRiVsRWiIoeOoghgcxBhed7lyih9jJvnpRd2ScIuUdgBrA0SLvt_5rK80XAA6_NmtHYKYajaNlddH7QtEccBrHYKmU-F0DGnSw0ByDuqmnegTNp3W-rZic-onYk8yvIkgI-DUm-91oNf8Ob_X_ABnqJ1lrvb-ztv4RkN8gTAbA0W2osr-w4dmVa_9xb6FytU87A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+miR-451+in+resistance+to+paclitaxel+by+regulating+YWHAZ+in+breast+cancer&rft.jtitle=Cell+death+%26+disease&rft.au=Wang%2C+Wenrui&rft.au=Zhang%2C+Lingyu&rft.au=Wang%2C+Yangyang&rft.au=Ding%2C+Yongxing&rft.date=2017-10-05&rft.eissn=2041-4889&rft.volume=8&rft.issue=10&rft.spage=e3071&rft_id=info:doi/10.1038%2Fcddis.2017.460&rft_id=info%3Apmid%2F28981108&rft.externalDocID=28981108 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |